NZ335633A - Production of recombinant H. pylori polypeptides for treatment and diagnosis of H. pylori related diseases - Google Patents

Production of recombinant H. pylori polypeptides for treatment and diagnosis of H. pylori related diseases

Info

Publication number
NZ335633A
NZ335633A NZ335633A NZ33563397A NZ335633A NZ 335633 A NZ335633 A NZ 335633A NZ 335633 A NZ335633 A NZ 335633A NZ 33563397 A NZ33563397 A NZ 33563397A NZ 335633 A NZ335633 A NZ 335633A
Authority
NZ
New Zealand
Prior art keywords
pylori
polypeptides
recombinant
diagnosis
treatment
Prior art date
Application number
NZ335633A
Other languages
English (en)
Inventor
Douglas Smith
Richard A Alm
Peter C Doig
Zita Kabok
Lillian Marie Castriotta
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of NZ335633A publication Critical patent/NZ335633A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/205Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Campylobacter (G)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K2039/106Vibrio; Campylobacter; Not used, see subgroups
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
NZ335633A 1996-12-05 1997-12-05 Production of recombinant H. pylori polypeptides for treatment and diagnosis of H. pylori related diseases NZ335633A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US75962596A 1996-12-05 1996-12-05
US82374597A 1997-03-25 1997-03-25
US89192897A 1997-07-14 1997-07-14
PCT/US1997/022104 WO1998024475A1 (en) 1996-12-05 1997-12-05 Nucleic acid and amino acid sequences relating to helicobacter pylori and vaccine compositions thereof

Publications (1)

Publication Number Publication Date
NZ335633A true NZ335633A (en) 2000-10-27

Family

ID=27419527

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ335633A NZ335633A (en) 1996-12-05 1997-12-05 Production of recombinant H. pylori polypeptides for treatment and diagnosis of H. pylori related diseases

Country Status (18)

Country Link
EP (1) EP0964699A4 (id)
JP (1) JP2001510992A (id)
KR (1) KR20000069297A (id)
CN (1) CN1246799A (id)
AR (1) AR010337A1 (id)
AU (1) AU739641B2 (id)
BR (1) BR9714133A (id)
CA (1) CA2273199A1 (id)
EE (1) EE9900226A (id)
ID (1) ID21946A (id)
IL (1) IL129746A0 (id)
IS (1) IS5047A (id)
NO (1) NO992158L (id)
NZ (1) NZ335633A (id)
PL (1) PL333943A1 (id)
SK (1) SK57999A3 (id)
TR (1) TR199901262T2 (id)
WO (1) WO1998024475A1 (id)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6188599A (en) * 1998-10-26 2000-05-15 Novozymes A/S Constructing and screening a dna library of interest in filamentous fungal cells
US7034132B2 (en) 2001-06-04 2006-04-25 Anderson David W Therapeutic polypeptides, nucleic acids encoding same, and methods of use
AUPQ347199A0 (en) * 1999-10-15 1999-11-11 Csl Limited Novel polypeptide fragments
US6951729B1 (en) 1999-10-27 2005-10-04 Affinium Pharmaceuticals, Inc. High throughput screening method for biological agents affecting fatty acid biosynthesis
US7048926B2 (en) 2000-10-06 2006-05-23 Affinium Pharmaceuticals, Inc. Methods of agonizing and antagonizing FabK
AU2000277557A1 (en) * 2000-10-06 2002-04-22 Smith Kline Beecham Corporation Methods of agonizing and antagonizing fabk
WO2002066502A1 (en) * 2001-02-21 2002-08-29 Boren Thomas Helicobacter pylori sialic acid binding adhesin, saba and saba - gene
CN102176907A (zh) * 2008-10-08 2011-09-07 免疫解决方案有限公司 用于产生粘膜免疫的口服疫苗
JP6959937B2 (ja) * 2015-12-14 2021-11-05 テクニシェ ユニバーシタット ミュンヘン ヘリコバクターピロリワクチン
CN110343697B (zh) * 2019-08-05 2024-07-12 南京昊斯亭网络科技有限公司 一种植物病害菌总dna提取方法
CN113435168B (zh) * 2021-06-10 2024-03-22 上海美吉生物医药科技有限公司 胶图自动编辑方法、系统、终端及介质
CN114057854B (zh) * 2021-09-30 2022-07-15 河北医科大学第四医院 一种幽门螺杆菌cd4+t细胞耐受多肽融合抗原及其应用
CN116162140A (zh) * 2022-07-19 2023-05-26 四川大学华西医院 一种幽门螺杆菌重组抗原蛋白SecG及其制备方法与应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9300139L (sv) * 1993-01-19 1994-07-20 Medicarb Ab Framställning av ett nytt läkemedel

Also Published As

Publication number Publication date
TR199901262T2 (xx) 1999-08-23
AR010337A1 (es) 2000-06-07
AU5895498A (en) 1998-06-29
CN1246799A (zh) 2000-03-08
SK57999A3 (en) 2000-05-16
EE9900226A (et) 1999-12-15
KR20000069297A (ko) 2000-11-25
PL333943A1 (en) 2000-01-31
AU739641B2 (en) 2001-10-18
NO992158L (no) 1999-07-05
BR9714133A (pt) 2000-02-29
CA2273199A1 (en) 1998-06-11
EP0964699A1 (en) 1999-12-22
WO1998024475A1 (en) 1998-06-11
EP0964699A4 (en) 2005-04-06
IL129746A0 (en) 2000-02-29
IS5047A (is) 1999-05-10
ID21946A (id) 1999-08-12
JP2001510992A (ja) 2001-08-07
NO992158D0 (no) 1999-05-04

Similar Documents

Publication Publication Date Title
GB2181138B (en) Recombinant alveolar surfactant protein
WO2000034317A3 (en) Method for reducing immunogenicity of proteins
ATE173478T1 (de) Varianten des pankreatischen rinder- trypsininhibitors, deren herstellung und verwendung
EP2258383A3 (en) Antigenic peptides derived from telomerase
DK0662827T4 (da) Terapeutiske og diagnostiske fremgangsmåder og sammensætninger baseret på Notch-proteiner og nucleinsyrer
ZA943465B (en) Transforming growth factor alpha H1
NZ335633A (en) Production of recombinant H. pylori polypeptides for treatment and diagnosis of H. pylori related diseases
EP0825996A4 (en) FACTOR-1 (FHF-1) HOMOLOGATED FIBROBLAST GROWTH FACTOR AND METHODS OF USE
WO2002008277A3 (en) Nucleic acids, vectors, host cells, polypeptides, and uses thereof
IL82364A0 (en) Recombinant alveolar surfactant protein,its production and purification and pharmaceutical compositions containing it
CA2175332A1 (en) Haemophilus transferrin receptor genes
NZ500540A (en) Purified proteins, fusion proteins, recombinant vector, vaccine, kit, comprising proteins from Actinobacillus pleuropneumoniae
NZ332565A (en) Nucleic acid and amino acid sequences relating to helicobacter pylori and vaccine compositions thereof
NO991995L (no) Nukleinsyre- og aminosyresekvenser relatert til Heliobacter pylori og vaksinesammensetninger derav
HK1046648B (zh) 包括最少兩個不同變應原蛋白的含雜種多肽疫苗
CA2096532A1 (en) New human recombinant gamma-interferon
AU5776799A (en) Modified hcv peptide vaccines
WO2000029434A3 (en) PNEUMOCOCCAL CHOLINE BINDING PROTEINS, CbpG AND CbpD, DIAGNOSTIC AND THERAPEUTIC USES THEREOF
DK595187A (da) Minactivin og fremgangsmaade til fremstilling deraf
EP0490383A3 (en) Peptides of the hiv-gag protein, their preparation and use
DE69012989D1 (de) Peptiden von retinblastoma gen produkten und antikoerper dagegen.
AU2001239262A1 (en) Haemophilus influenza outer membrane protein and use thereof in vaccination
MX9709846A (es) Secuencias de acidos nucleico y aminoacidos relacionados con el helicobacter pylori para procedimientos de diagnostico y terapeuticos.
CA2067334A1 (en) Recombinant production of lactoperoxidase
WO1998044094A3 (en) Helicobacter aliphatic amidase polypeptides, dna sequences encoding those polypeptides and uses thereof

Legal Events

Date Code Title Description
RENW Renewal (renewal fees accepted)